Latest APRE reports update at 2024-05-14: 2024-Q12023-Q42023-Q1
Aprea Therapeutics logo
Aprea Therapeutics APRE
$ 5.5 7.11%

Aprea Therapeutics Interest Expense 2011-2024 | APRE

Annual Interest Expense Aprea Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.19 M 730 K 319 K -668 K 1.48 M 961 K 662 K - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.48 M -668 K 668 K

Quarterly Interest Expense Aprea Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
340 K - 318 K 393 K 243 K - 175 K 207 K 138 K - -21.9 K -253 K 521 K - -83.8 K -1.89 M 2.47 M - 969 K 676 K 933 K - -208 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.47 M -1.89 M 290 K